Barclays’s Clover Health Investments CLOV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.24M | Buy |
800,674
+354,520
| +79% | +$990K | ﹤0.01% | 2154 |
|
|
2025
Q1 | $1.6M | Sell |
446,154
-15,538
| -3% | -$55.8K | ﹤0.01% | 2178 |
|
|
2024
Q4 | $1.45M | Buy |
461,692
+355,926
| +337% | +$1.12M | ﹤0.01% | 2404 |
|
|
2024
Q3 | $298K | Buy |
+105,766
| New | +$298K | ﹤0.01% | 3289 |
|
|
2024
Q2 | – | Sell |
-75,915
| Closed | -$60K | – | 4200 |
|
|
2024
Q1 | $60K | Sell |
75,915
-471,146
| -86% | -$372K | ﹤0.01% | 3780 |
|
|
2023
Q4 | $520K | Buy |
547,061
+481,828
| +739% | +$458K | ﹤0.01% | 2973 |
|
|
2023
Q3 | $70K | Buy |
65,233
+1,589
| +2% | +$1.71K | ﹤0.01% | 3452 |
|
|
2023
Q2 | $57K | Sell |
63,644
-172,612
| -73% | -$155K | ﹤0.01% | 3615 |
|
|
2023
Q1 | $199K | Buy |
236,256
+81,618
| +53% | +$68.7K | ﹤0.01% | 3153 |
|
|
2022
Q4 | $144K | Buy |
154,638
+87,349
| +130% | +$81.3K | ﹤0.01% | 3264 |
|
|
2022
Q3 | $115K | Buy |
67,289
+13,555
| +25% | +$23.2K | ﹤0.01% | 3359 |
|
|
2022
Q2 | $115K | Buy |
53,734
+51,694
| +2,534% | +$111K | ﹤0.01% | 3408 |
|
|
2022
Q1 | $7K | Buy |
+2,040
| New | +$7K | ﹤0.01% | 4534 |
|